Pexidartinib
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Pexidartinib, covering 2020-01-10 to 2025-03-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan [Phase 2]